Aminoglutethimide (High Purity)

Product Description

Aminoglutethimide (High Purity)
Catalog number: B2010692
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 50 mg
Molecular Weight or Concentration: 232.28 g/mol
Supplied as: Powder
Applications: molecular tool for various chemical and biochemical applications
Storage: RT
Keywords: 3-(p-Aminophenyl)-3-ethylpiperidine-2,6-dione, DL-Aminoglutethimide, 3-(4-Aminophenyl)-3-ethyl-2,6-piperidinedione
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

References:
1: Aminoglutethimide Lancet. 1981 May 30;1(8231):1194-5.
2: Santen RJ, Misbin RI. Aminoglu_tethimide: review of pharmacology and clinical use Pharmacotherapy. 1981 Sep-Oct;1(2):95-120.
3: Shaw MA, Nicholls PJ, Smith HJ. Aminoglu_tethimide and ketoconazole: historical perspectives and future prospects J Steroid Biochem. 1988 Jul;31(1):137-46.
4: Cocconi G. First generation aromatase inhibitors–aminoglu_tethimide and testololactone Breast Cancer Res Treat. 1994;30(1):57-80.
5: Hughss SW, Burley DM. Aminoglu_tethimide: a “side-effect” turned to therapeutic advantage Postgrad Med J. 1970 Jul;46(537):409-16.
6: Stuart-Harris RC, Smith IE. Aminoglu_tethimide in the treatment of advanced breast cancer Cancer Treat Rev. 1984 Sep;11(3):189-204.
7: Aminoglutethimide Med Lett Drugs Ther. 1981 Aug 7;23(16):71-2.
8: Lønning PE, Kvinnsland S. Mechanisms of action of aminoglu_tethimide as endocrine therapy of breast cancer Drugs. 1988 Jun;35(6):685-710.
9: Huang HY, Fei LM, Liu WH. [Advanced breast cancer treated with aminoglutethimide] Zhonghua Yi Xue Za Zhi. 1986 Mar;66(3):178-81.
10: Mutsuga M, Asaoka Y, Imura N, Miyoshi T, Togashi Y. Aminoglutethimide-induced lysosomal changes in adrenal gland in mice Exp Toxicol Pathol. 2017 Sep 5;69(7):424-429.

Products Related to Aminoglutethimide (High Purity): Chemicals